v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Sales, net of returns and allowances $ 640,922 $ 1,339,295
Cost of sales 5,164,763 7,442,778
Gross loss (4,523,841) (6,103,483)
Operating expenses    
Selling, general and administrative 6,783,911 14,095,278
Research and development 1,529,019 3,527,911
Total operating expenses 8,312,930 17,623,189
Loss from operations (12,836,771) (23,726,672)
Interest income (expense), net (5,252,228) (1,164,593)
Change in fair value adjustment on convertible notes (3,272,095) (467,874)
Change in fair value adjustment on warrants 716,960 (3,796,648)
Loss before provision for income taxes (20,644,134) (29,155,787)
Provision for income taxes 0 0
Net loss $ (20,644,134) $ (29,155,787)
Net loss per share of common stock    
Basic (in usd per share) [1] $ (4.68) $ (24.09)
Diluted (in usd per share) [1] $ (4.68) $ (24.09)
Weighted average shares used in computing net loss per share of common stock    
Basic (in shares) [1] 4,409,194 1,210,429
Diluted (in shares) [1] 4,409,194 1,210,429
[1] Periods presented have been adjusted to reflect the 2024 reverse stock split (1-for-20), which was effective June 17, 2024 and the 2025 reverse stock split (1-for-12.5) which was effective March 17, 2025. Additional information regarding the reverse stock splits may be found in Note 1 – Summary of Business and Significant Accounting Principles to this Condensed Consolidated Financial Statement in this Quarterly Report on Form 10-Q

Source